When you pause to think about cancer—where we’ve been, and how far we still have to go—it’s easy to picture progress as a single breakthrough moment.
We’ve all seen the movie version of discovery.
A lone researcher.
A late night in the lab.
A glowing microscope.
And suddenly—Eureka!
It’s a great story.
It’s just not how most childhood cancer research actually works.
In cancer research, solutions are rarely sudden—and almost never the result of a single moment, person, or experiment.
Instead, progress is built slowly, carefully, and intentionally—over years, sometimes decades.
Research Is a Process, Not a Moment
At its core, research is a series of questions and answers.
A researcher starts with a hypothesis—an educated guess. They test it, learn from the results, and use that knowledge to ask the next question. Then they repeat the process. Again and again.
Scientists call this iterative research. Most people experience it as persistence.
Each step forward may feel small. But taken together, these steps are how survival rates for some childhood cancers have improved from nearly zero to nearly 90% in some types, over time.
And for cancers where progress has been slower—or harder to detect—that same process continues. Because children with cancer can’t be left behind simply because the road is long.
From Idea to Treatment: The Long Road of Cancer Research
Think of childhood cancer research as a very long journey. There’s a destination in mind—safer, more effective treatments—but the route includes detours, setbacks, and unexpected turns.
Here’s how that journey typically unfolds:
1. Basic Research & Drug Discovery
This is where everything begins. Scientists explore thousands—sometimes tens of thousands—of possibilities to understand how cancer works at the most fundamental level.
Most ideas won’t turn into treatments. That’s not failure—it’s how science narrows the path forward.
2. Pre-Clinical & Translational Research
Promising discoveries are tested and refined, helping researchers determine which ideas are ready to move closer to patient care.
3. Clinical Trials (Phases I, II, and III)
New therapies are carefully studied with patients to evaluate safety, dosing, and effectiveness—step by step.
4. FDA Approval
Only after years of evidence can a treatment become widely available to all children who need it.
This journey relies on many kinds of research working together—from early discovery to patient care—and on people who believe that progress is worth investing in, even when the results take time.
BIG NEWS: FDA Approves Groundbreaking CAR T Cell Therapy for Kids With Leukemia >>
Progress Is Built, Not Discovered
Breakthroughs do happen. But they almost always rest on years of work that came before.
Today’s treatments exist because someone invested in research they knew they might never personally benefit from.
And tomorrow’s cures depend on what we choose to support today.
You can help make that future possible. Your support funds the researchers, studies, and discoveries that keep the work going — step by step, question by question, child by child.
Ready to learn more? Check out our next blog about the types of research that move discoveries forward.
